QUESTIONS / 06
TB-500 questions answered without sales talk
Each answer says what happened and names the catch. Most hopeful work used full thymosin beta-4 instead of the fragment.
The fragment is one small part of a larger protein
What is the key fact about TB-500? It may not act like whole thymosin beta-4.
Studies haven't proved that the short piece does the same jobs. The answers below keep that difference clear.
TB-500 is a lab-made piece of protein
TB-500 copies parts 17 through 23 of thymosin beta-4. The whole protein has many linked parts, like a chain [5].
Your body makes the whole protein. It doesn't make the fragment.
TB links the TB-500 name to thymosin beta; 500 is a catalog number
The letters TB point to thymosin beta. The number 500 isn't a dose.
The thymosin beta-4 fragment is made in a lab. Some sellers call the lab-made fragment TB1000.
Most repair studies used whole thymosin beta-4
Studies have examined wounds, muscles, ligaments, hearts, and brains [5]. Most tested the whole protein instead of TB-500.
Those results explain why the fragment draws interest. They don't prove it works.
TB-500 copies a part that joins actin
Actin is a protein that helps cells keep shape and move. Whole thymosin beta-4 joined it in a 1:1 lab match [1].
TB-500 copies the part used at that join. The count doesn't prove that the short piece heals people.
Animal healing signs have not become human results
TB-500 Muscle Recovery isn't proved in people
Did the thymosin beta-4 fragment heal human muscle? No fair TB-500 trial has shown human muscle healing.
In animals, injured muscle released thymosin beta-4. The whole protein drew young muscle cells toward the damage [7].
A rat ligament healed, but TB-500 claims remain unproved
A torn rat knee ligament healed better with whole thymosin beta-4 [8]. The thymosin beta-4 study didn't test a person or TB-500.
It didn't test a tendon either. Wider joint claims go past the finding.
Rat skin timing can't set your healing time
No human study gives a TB-500 healing time. Rat skin grew back 42% more by 4 days.
The gain reached 61% at 7 days with the whole protein [3]. A rat wound can't predict your recovery.
Heart findings were mixed in animals
Mouse heart cells fared better after blood flow stopped [2]. A pig study found no clear drop in heart harm.
Both studies used whole thymosin beta-4. Neither proves that TB-500 helps a human heart.
Rat stroke gains didn't rise with the amount
Rats improved after 2 and 12 milligrams for each kilogram of body weight. They didn't improve after 18 milligrams for each kilogram.
A thymosin beta-4 math estimate put the best point near 3.75 milligrams for each kilogram [4]. The study used the whole protein and gives no human amount.
TB-500 blood-vessel claims carry a concern
Whole thymosin beta-4 helped blood-vessel cells move [10]. The result brings 1 clear concern.
New vessels may aid a wound, but tumors also use them. The study didn't prove TB-500 causes either result.
Hair claims come from rodents
In rodents, the whole protein helped cells near hair roots move [5]. The study didn't prove human hair growth from TB-500.
Personal stories can't close that gap. The hair claim remains weak.
Swelling claims come from eyes and cells in dishes
Whole thymosin beta-4 quieted one cause of eye swelling [12]. Tests in cells in a dish also found less swelling activity.
No human study shows TB-500 easing your sore joint. The claim still runs ahead of proof.
Human safety studies are too thin for firm answers
TB-500 cancer risk is possible, not proved
Several cancers contain high amounts of whole thymosin beta-4 [13]. The protein may help cells move and new tumor vessels grow.
That doesn't prove TB-500 causes cancer. It gives you and your doctor a reason for care.
TB-500 Side Effects remain poorly known
The short piece has little human safety work [13]. Research vials may hold the wrong substance or be dirty.
A 2026 review warns of possible serious harm [14]. It can't tell us how often harm occurs.
Human trials tested the whole protein
No completed fair human trial has tested TB-500 [13]. A Phase 1 study, the first small safety check, used whole thymosin beta-4 [6].
Eye trials also used the whole protein. Those thymosin beta-4 trials can't prove TB-500 is safe or works.
TB-500 and BPC-157 aren't the same
TB-500 copies part of thymosin beta-4 [5]. BPC-157 is based on a different substance found in stomach juice.
A 2026 Sports Medicine review says neither is approved for muscle or joint injuries [14]. Neither has strong human proof for repair.
No repair product wins on good human proof
A 2026 review found hopeful animal results for several products sold for repair [14]. The review also found little good human safety work.
Sales pages may still rank them. The evidence doesn't support a firm winner.
Study amounts don't create a human dosing plan
TB-500 loading plans aren't based on human trials
A loading plan means taking more at the start, then less later. Online plans of that kind haven't been proved in fair human trials [13].
Animal studies gave whole thymosin beta-4 based on body weight [4]. You can't turn those amounts into a safe weekly plan.
Human tests haven't compared shot sites
Rodent studies mainly used belly shots [4]. People using the fragment outside trials report shots under skin or into muscle [13].
No fair human trial compares those two ways. A claim that one works better lacks proof.
TB-500 Half-Life is unknown in people
No human study has set TB-500's half-life, the time needed for your body to clear half an amount [13]. That leaves safe timing unknown.
Phase 1 thymosin beta-4 work found that more of the whole protein stayed longer [6]. That finding gives no safe timing for TB-500.
Current law limits pharmacy access and tested athletes
TB-500 is not an approved U.S. drug
Is TB-500 approved? No; FDA lists it as a short piece of thymosin beta-4.
FDA placed it in Category 2 because of possible serious safety risks [17]. FDA now records the fragment under withdrawn nominations; its stated safety concerns remain [17].
A prescription can't erase the substance rule
Mixed drugs need a valid prescription after a licensed doctor checks the patient. They may come from a 503A pharmacy or a 503B batch-making site [18].
Current TB-500 prescription care involves a licensed U.S. clinician's decision on the person requesting it. The clinician can decline, and the patient's state and treatment constrain the choices within U.S. care. Compounded TB-500 has no FDA approval [17].
FDA records a withdrawn TB-500 nomination
FDA placed the thymosin beta-4 short piece called TB-500 in Category 2. That nomination is now withdrawn, rather than pending within Category 2 [17].
FDA cited possible immune harm and too little safety information. An advisory meeting entry is separate from a final FDA decision about the 503A list [16][18].
Tested athletes can't use TB-500
TB-500 and thymosin beta-4 are banned both during and outside contests [13]. Drug tests can find TB-500 in horse and human samples.
Calling its use research doesn't change the ban. Tested athletes still face the same rule.
TB-500 remains an unapproved drug
TB-500 has no approved medical use [17]. Sellers label TB-500 for research or animal use rather than approved care.
Pharmacy mixing is a second issue. Withdrawal alone supplies no permission for a specific compounded preparation [17][18].